Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Collagenex Pharmaceuticals Inc (CGPI) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Collagenex Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1012270.
Total stock buying since 2005: $196,197.
Total stock sales since 2005: $2,201,228.
Total stock option exercises since 2005: $1,905,483.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 33,334 | $390,667 | 50,001 | $312,502 |
| 2007 | 5,400 | $42,450 | 73,333 | $931,032 | 73,333 | $721,881 |
| 2006 | 0 | $0 | 66,100 | $879,529 | 90,000 | $871,100 |
| 2005 | 30,800 | $153,747 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-02 | 0 | $0 | 6,667 | $81,870 | 23,334 | $145,836 |
| 2008-01 | 0 | $0 | 26,667 | $308,797 | 26,667 | $166,666 |
| 2007-11 | 5,200 | $40,354 | 0 | $0 | 0 | $0 |
| 2007-08 | 0 | $0 | 8,333 | $110,412 | 8,333 | $52,081 |
| 2007-07 | 0 | $0 | 30,000 | $383,130 | 30,000 | $318,750 |
| 2007-06 | 0 | $0 | 30,000 | $366,340 | 30,000 | $318,750 |
| 2007-05 | 200 | $2,096 | 0 | $0 | 0 | $0 |
| 2007-04 | 0 | $0 | 5,000 | $71,150 | 5,000 | $32,300 |
| 2006-11 | 0 | $0 | 16,667 | $233,337 | 46,667 | $442,503 |
| 2006-09 | 0 | $0 | 49,433 | $646,192 | 33,333 | $299,997 |
| 2006-06 | 0 | $0 | 0 | $0 | 10,000 | $128,600 |
| 2005-06 | 30,800 | $153,747 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-02-08 | Broadbent Nancy C (CFO and Treasurer) | Option Ex | 16,667 | 6.25 | 104,168 |
| 2008-02-04 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 6,667 | 12.28 | 81,870 |
| 2008-02-04 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 6,667 | 6.25 | 41,668 |
| 2008-01-28 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 13,334 | 11.81 | 157,514 |
| 2008-01-28 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 13,334 | 6.25 | 83,336 |
| 2008-01-22 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 6,666 | 10.88 | 72,526 |
| 2008-01-22 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 6,666 | 6.25 | 41,662 |
| 2007-11-28 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Buy | 200 | 7.30 | 1,460 |
| 2007-11-28 | Theobald Klaus (Sr VP & Chief Medical Officer) | Buy | 1,050 | 7.41 | 7,780 |
| 2007-11-27 | Theobald Klaus (Sr VP & Chief Medical Officer) | Buy | 300 | 7.41 | 2,223 |
| 2007-11-20 | Ford James Gregory (VP, Business Development) | Buy | 1,500 | 7.87 | 11,805 |
| 2007-11-20 | Theobald Klaus (Sr VP & Chief Medical Officer) | Buy | 1,300 | 7.75 | 10,071 |
| 2007-11-16 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Buy | 400 | 8.01 | 3,204 |
| 2007-11-08 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Buy | 450 | 8.47 | 3,811 |
| 2007-08-09 | Broadbent Nancy C (CFO and Treasurer) | Sale | 8,333 | 13.25 | 110,412 |
| 2007-08-09 | Broadbent Nancy C (CFO and Treasurer) | Option Ex | 8,333 | 6.25 | 52,081 |
| 2007-07-16 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.65 | 126,510 |
| 2007-07-16 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 10,000 | 10.62 | 106,250 |
| 2007-07-09 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.87 | 128,680 |
| 2007-07-09 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 10,000 | 10.62 | 106,250 |
| 2007-07-02 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.79 | 127,940 |
| 2007-07-02 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 10,000 | 10.62 | 106,250 |
| 2007-06-25 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.35 | 123,510 |
| 2007-06-25 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 10,000 | 10.62 | 106,250 |
| 2007-06-18 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.24 | 122,420 |
| 2007-06-18 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 10,000 | 10.62 | 106,250 |
| 2007-06-11 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.04 | 120,410 |
| 2007-06-11 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Ex | 10,000 | 10.62 | 106,250 |
| 2007-05-22 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Buy | 200 | 10.48 | 2,096 |
| 2007-04-19 | Ford James Gregory (VP, Business Development) | Sale | 5,000 | 14.23 | 71,150 |
| 2007-04-19 | Ford James Gregory (VP, Business Development) | Option Ex | 5,000 | 6.46 | 32,300 |
| 2006-11-09 | Easton Robert J | Option Ex | 15,000 | 9.75 | 146,250 |
| 2006-11-09 | Daverman James E | Option Ex | 15,000 | 9.75 | 146,250 |
| 2006-11-07 | Broadbent Nancy C (CFO and Treasurer) | Sale | 8,334 | 14.25 | 118,759 |
| 2006-11-07 | Broadbent Nancy C (CFO and Treasurer) | Option Ex | 8,334 | 9.00 | 75,006 |
| 2006-11-06 | Broadbent Nancy C (CFO and Treasurer) | Sale | 8,333 | 13.75 | 114,578 |
| 2006-11-06 | Broadbent Nancy C (CFO and Treasurer) | Option Ex | 8,333 | 9.00 | 74,997 |
| 2006-09-26 | Broadbent Nancy C (CFO and Treasurer) | Sale | 6,132 | 13.25 | 81,249 |
| 2006-09-26 | Broadbent Nancy C (CFO and Treasurer) | Option Ex | 6,132 | 9.00 | 55,188 |
| 2006-09-25 | Broadbent Nancy C (CFO and Treasurer) | Sale | 2,201 | 13.25 | 29,163 |
| 2006-09-25 | Broadbent Nancy C (CFO and Treasurer) | Option Ex | 2,201 | 9.00 | 19,809 |
| 2006-09-19 | Daverman James E | Sale | 13,000 | 13.06 | 169,780 |
| 2006-09-18 | Easton Robert J | Sale | 10,000 | 13.07 | 130,700 |
| 2006-09-15 | Barnett Peter R | Sale | 18,100 | 13.00 | 235,300 |
| 2006-09-15 | Barnett Peter R | Option Ex | 25,000 | 9.00 | 225,000 |
| 2006-06-05 | Easton Robert J | Option Ex | 10,000 | 12.86 | 128,600 |
| 2005-06-15 | Daverman James E (Director) | Buy | 20,000 | 5.03 | 100,640 |
| 2005-06-13 | Powell Andrew Kenneth William (VP, G. Counsel and C) | Buy | 1,800 | 4.87 | 8,757 |
| 2005-06-10 | Stewart Colin W (President and CEO) | Buy | 5,000 | 4.95 | 24,750 |
| 2005-06-10 | Pfeiffer David F (Sr. VP, Sales and Ma) | Buy | 4,000 | 4.90 | 19,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of CGPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Collagenex Pharmaceuticals Inc (symbol CGPI, CIK number 1012270) see the Securities and Exchange Commission (SEC) website.